(NASDAQ: QTRX) Quanterix's forecast annual revenue growth rate of 21.05% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.02%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.49%.
Quanterix's revenue in 2026 is $138,897,000.On average, 6 Wall Street analysts forecast QTRX's revenue for 2026 to be $8,179,290,644, with the lowest QTRX revenue forecast at $7,295,880,314, and the highest QTRX revenue forecast at $8,723,794,354. On average, 6 Wall Street analysts forecast QTRX's revenue for 2027 to be $9,310,544,041, with the lowest QTRX revenue forecast at $8,703,610,165, and the highest QTRX revenue forecast at $9,837,679,961.
In 2028, QTRX is forecast to generate $12,012,878,402 in revenue, with the lowest revenue forecast at $11,541,601,053 and the highest revenue forecast at $12,366,336,414.